(3-Formyl-2-methoxy-5-methylphenyl)boronic acid, 95.0%, 250mg

(S)-(4-(Prop-1-en-2-yl)cyclohex-1-en-1-yl)methanol, 95.0%, 10g

4-Amino-6-chloropyridin-3-ol, 95.0%, 1g

3-Chloroazetidine hydrochloride, 95.0%, 25g

1-tert-Butyl 4-ethyl 4-formylpiperidine-1,4-dicarboxylate, 95%, 100mg

3-(2-Cyanopropan-2-yl)-N-(3-((7-methoxyquinazolin-4-yl)amino)-4-methylphenyl)benzamide, 97.0%, 100mg

2-Ethyl-4,5,6,7-tetrahydro-2H-indazole-3-carboxylic acid, 98%, 250mg

Ethyl 5-(1-hydroxyethyl)-3-phenylisoxazole-4-carboxylate, 95.0%, 1g

2,4-dibromo-5-chloropyrimidine, 98%, 250mg

2-Fluoro-5-sulfino-benzoic acid, 95.0%, 100mg

8-chloro-2-(2-methylphenyl)quinoline-4-carboxylic acid, 95.0%, 1g

Methyl 1-Phenylcyclobutanecarboxylate, 97.0%, 250mg

o-Nitrotoluene, min 99%, for synthesis, 1L, glass packaging